O'Byrne KJ - Search Results

1

Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi.

Suraweera A, O'Byrne KJ, Richard DJ. Suraweera A, et al. Front Oncol. 2018 Mar 29;8:92. doi: 10.3389/fonc.2018.00092. eCollection 2018. Front Oncol. 2018. PMID: 29651407 Free PMC article. Review.

2

PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancer.

Paul I, Savage KI, Blayney JK, Lamers E, Gately K, Kerr K, Sheaff M, Arthur K, Richard DJ, Hamilton PW, James JA, O'Byrne KJ, Harkin DP, Quinn JE, Fennell DA. Paul I, et al. J Pathol. 2011 Aug;224(4):564-74. doi: 10.1002/path.2925. Epub 2011 Jun 27. J Pathol. 2011. PMID: 21706479

3

BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma.

Busacca S, Sheaff M, Arthur K, Gray SG, O'Byrne KJ, Richard DJ, Soltermann A, Opitz I, Pass H, Harkin DP, Quinn JE, Fennell DA. Busacca S, et al. J Pathol. 2012 Jun;227(2):200-8. doi: 10.1002/path.3979. Epub 2012 Mar 19. J Pathol. 2012. PMID: 22190288

4

Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.

O'Flaherty JD, Gray S, Richard D, Fennell D, O'Leary JJ, Blackhall FH, O'Byrne KJ. O'Flaherty JD, et al. Lung Cancer. 2012 Apr;76(1):19-25. doi: 10.1016/j.lungcan.2011.10.018. Epub 2011 Dec 29. Lung Cancer. 2012. PMID: 22209049 Review.

5

The cancer stem-cell hypothesis: its emerging role in lung cancer biology and its relevance for future therapy.

O'Flaherty JD, Barr M, Fennell D, Richard D, Reynolds J, O'Leary J, O'Byrne K. O'Flaherty JD, et al. J Thorac Oncol. 2012 Dec;7(12):1880-1890. doi: 10.1097/JTO.0b013e31826bfbc6. J Thorac Oncol. 2012. PMID: 23154562 Free article. Review.

6

Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature.

Barr MP, Gray SG, Hoffmann AC, Hilger RA, Thomale J, O'Flaherty JD, Fennell DA, Richard D, O'Leary JJ, O'Byrne KJ. Barr MP, et al. PLoS One. 2013;8(1):e54193. doi: 10.1371/journal.pone.0054193. Epub 2013 Jan 17. PLoS One. 2013. PMID: 23349823 Free PMC article.

7

Human single-stranded DNA binding proteins are essential for maintaining genomic stability.

Ashton NW, Bolderson E, Cubeddu L, O'Byrne KJ, Richard DJ. Ashton NW, et al. BMC Mol Biol. 2013 Apr 1;14:9. doi: 10.1186/1471-2199-14-9. BMC Mol Biol. 2013. PMID: 23548139 Free PMC article. Review.

8

Genome stability pathways in head and neck cancers.

Jenkins G, O'Byrne KJ, Panizza B, Richard DJ. Jenkins G, et al. Int J Genomics. 2013;2013:464720. doi: 10.1155/2013/464720. Epub 2013 Nov 4. Int J Genomics. 2013. PMID: 24364026 Free PMC article. Review.

9

Chemotherapeutic compounds targeting the DNA double-strand break repair pathways: the good, the bad, and the promising.

Jekimovs C, Bolderson E, Suraweera A, Adams M, O'Byrne KJ, Richard DJ. Jekimovs C, et al. Front Oncol. 2014 Apr 22;4:86. doi: 10.3389/fonc.2014.00086. eCollection 2014. Front Oncol. 2014. PMID: 24795863 Free PMC article. Review.

10

Functions and therapeutic roles of exosomes in cancer.

Tickner JA, Urquhart AJ, Stephenson SA, Richard DJ, O'Byrne KJ. Tickner JA, et al. Front Oncol. 2014 May 27;4:127. doi: 10.3389/fonc.2014.00127. eCollection 2014. Front Oncol. 2014. PMID: 24904836 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

412 results

Search Page